Epicardial adipose tissue as a cardiovascular risk marker

Future Lipidology

Volumn 4, Issue 1, 2009, Pages 55-62

  McLean, Dalton S ^a   Stillman, Arthur E ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Adipokines; Coronary artery disease risk; Epicardial adipose tissue; Pericardial fat; Visceral fat

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CHEMOKINE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANGIOCARDIOGRAPHY; ARTERY CALCIFICATION; ATHEROSCLEROSIS; BODY FAT DISTRIBUTION; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY SPASM; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ECHOCARDIOGRAPHY; EPICARDIAL ADIPOSE TISSUE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART RIGHT VENTRICLE; HUMAN; INTRAABDOMINAL FAT; LYMPHOCYTE; MACROPHAGE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PATHOPHYSIOLOGY; PERICARDIUM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; TISSUE LEVEL;

EID: 67149121897     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/17584299.4.1.55     Document Type: Review

References (63)

1. Calle CE, Thun MI, Petrelli JM, Rodriguez C, Heath CWJ: Body-mass index and mortality in a prospective cohort of U.S. adults. N. Engl. J. Med. 341, 1097-1105 (1999).
2. Despres JP: Is visceral obesity the cause of the metabolic syndrome? Ann: Med. 38, 52-63 (2006).
3. Bjorntorp P: Metabolic implications of body fat distribution. Diabetes Care 14, 1132-1143 (1991).
4. Lebovitz HE, Banerji MA: Point: visceral adiposity is causally related to insulin resistance. Diabetes Care 28, 2322-2325 (2005).
5. Zamboni M, Armellini F, Sheiban I et al.: Relation of body fat distribution in men and degree of coronary narrowings in coronary artery disease. Am. J. Cardiol. 70, 1135-1138 (1992).
6. Folsom AR, Prineas RJ, Kaye SA, Munger RG: Incidence of hypertension and stroke in relation to body fat distribution and other risk factors in older women. Stroke 21, 701-706 (1992).
7. Bjorntorp P: Abdominal obesity and the development of noninsulin dependent diabetes mellitus. Diabetes Metab. Rev. 4, 615-622 (1988).
8. Folsom A, Kaye S, Sellers T et al.: Body fat distribution and 5-year risk of death in older women. JAMA 269, 483-487 (1993).
9. Lapidus L, Bengtsson C, Larrson B, Pennert K, Rybo E, Sjostrom J: Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br. Med. J. 289, 1257-1261 (1984).
10. Nakamura T, Kobayashi H, Yanagi K et al.: Importance of intraabdominal visceral fat accumulation to coronary atherosclerosis in heterozygous familial hypercholesterolemia. Int. J. Obes. Relat. Metab. Disord. 21, 580-586 (1997).
11. Matsuzama Y: Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience. Diabetes Metab. Rev. 13 (1), 3-13 (1997).
12. Ho E, Shimada Y: Formation of the epicardium studied with the scanning electron microscope. Dev. Biol. 66, 579-585 (1978).
13. Fain JN, Sacks HS, Buehrer B et al.: Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots. Int. J Obesity 32, 810-815 (2008).
14. Iacobellis G, Corradi D, Sharma AM: Epicardial adipose tissue: anatomic, biomolecular and clinical relationship with the heart. Nat. Clin. Prac. Cardiovasc. Med. 2, 536-543 (2005).
15. Fain JN: Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the non-fat cells. In: Interleukins: In Vitamins and Hormones. Litwick G (Ed.). Academic Press, San Diego, CA, USA 443-477 (2006).
16. Shioji K, Moriguchi A, Moriwaki S et al.: Hypoadiponectinemia implies the development of atherosclerosis in carotid and coronary arteries. J. Cardiol. 46, 105-112 (2005).
17. Sharma AM: Adipose tissue: a mediator of cardiovascular risk. Int. J. Obes. Relat. Metab. Disord. 26(Suppl. 4), S5-27 (2002).
18. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 105, 1135-1143(2002).
19. Cheng KH, Chu CS, Lee KT et al.: Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int. J. Obesity 32, 268-274 (2008).
20. Otsuka F, Sugiyama S, Kojima S et al.: Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. J. Am. Coll. Cardiol. 48, 1155-1162 (2006).
21. Iacobellis G, Pistilli D, Gucciardo M et al.: Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 29, 251-255 (2005).
22. Weisberg PS, McCann D, Desai M et al.: Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808 (2003).
23. Moreno PR, Purushothaman KR, Fuster V, O'Connor WN: Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability. Circulation 105, 2504-2511 (2002).
24. Shimokawa H, Ito A, Fukumoto Y et al.: Chronic treatment with IL-1β induces coronary intimal lesions and vasospastic responses in pigs in vivo. J. Clin. Invest. 97,
25. Miyara K, Shimokawa H, Kandabashi T 769-776 (1996). et al.: Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in pigs in vivo. Artheroscler. Thromb. Vasc. Biol. 20, 2351-2358 (2000).
26. Eiras S, Teijeira-Fernandez E, Shamagian LG, Fernandez AL, Vazquez-Boquete A, Gonzalez-Juanatey JR: Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue. Cytokine 43, 174-180 (2008).
27. Mazurek T, Zhang L, Zalewski A et al.: Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108, 2460-2466 (2003).
28. Robicsek F, Thubrikar MJ: The freedom from atherosclerosis of intramyocardial coronary arteries: reduction of mural stress - a key factor. Eur. J. Cardiothorac. Surg. 8, 228-235 (1994).
29. Kawawa Y, Ishikawa Y, Gomi T et al.: Detection of myocardial bridge and evaluation of its anatomical properties by coronary multislice spiral computed tomography. Eur. J. Radiol. 61, 130-138 (2007).
30. Ishii T, Asuwa N, Masuda S, Ishikawa Y, Kiguchi H, Shimada K: The effects of a myocardial bridge on coronary atherosclerosis and ischaemia. J. Pathol. 185, 4-9 (1998).
31. Ishii T, Asuwa N, Masuda S, Ishikawa Y, Kiguchi H, Shimada K: Atherosclerosis suppression in the left anterior descending coronary artery by the presence of myocardial bridge: an ultrastructural study. Mod. Pathol. 4, 424-431 (1991).
32. Schejbal V: Epicardial fatty tissue of the right ventricle morphology, morphometry and functional significance. Pneumologie 43, 490-499 (1989).
33. Iacobellis G, Assael F, Ribaudo MC et al.: Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes. Res. 11, 304-310 (2003).
34. Iacobellis G, Willens HJ, Barbaro G, Sharma AM: Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity 16, 887-892 (2008).
35. Fluchter S, Haghi D, Dinter D et al.: Volumetric assessment of epicardial adipose tissue with cardiovascular magnetic resonance imaging. Obesity 15 (4), 870-878 (2007).
36. Gorter PM, van Lindert ASR, de Vos AM et al.: Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease. Atherosclerosis 197, 896-903 (2008).
37. Nichols JH, Samy B, Nasir K et al.: Volumetric measurement of perigardial. adipose tissue from contrast-enhanced coronary computed tomography angiography: a reproducibility study. J. Cardiovasc. Comput. Tomogr. 2, 288-295 (2008).
38. Ding J, Kritchevsky SB, Harris TB et al.: The association of pericardial fat with calcified coronary plaque. Obesity 16, 1914-1919 (2008).
39. Rosito GA, Massaro JM, Hoffmann U et al.: Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 117, 605-613 (2008).
40. Ahn SG, Lim HS, Joe DY et al.: Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart 94, E7 (2008).
41. Wheeler GL, Shi R, Beck SR et al.: Pericardial and visceral adipose tissue measured volumetrically with computed tomography are highly associated in Type 2 diabetic families. Invest. Radiol. 40, 97-101 (2005).
42. Taguchi R, Takasu J, Itani I et al.: Pericardial fat accumulation in men as a risk factor for coronary artery disease. Atherosclerosis 157, 203-209 (2001).
43. Iacobellis G, Ribando MC, Assal F et al.: Episcardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J. Clin. Endocrinol. Metab. 88, 5163-5168 (2003).
44. Malavazos AE, Ermetici F, Coman C et al.: Influence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesity. Int. J. Cardiol. 121,132-134 (2007).
45. Sironi AM, Gastaldelli A, Mari A et al.: Visceral fat in hypertension: influence of insulin resistance and β-cell function. Hypertension 44, 127-133 (2004).
46. Silaghi A, Piercecchi-Marti M, Grino M et al. Epicardial adipose tissue extent: relationship with age, body fat distribution, and coronaropathy. Obesity 16(11), 2424-2430 (2008).
47. Iacobellis G, Ribaudo MC, Zappatereno A et al.: Relation between epicardial adipose tissue and left ventricular mass. Am. J. Cardiol. 94, 1084-1087 (2004).
48. Corradi D, Maestri R, Callegari S et al.: The ventricular epicardial fat is related to the myocardial mass in normal, ischemic, and hypertrophic hearts. Cardiovasc. Pathol. 13, 313-316 (2004).
49. Budoff MJ, Achenbach S, Blumenthal RS et al.: Assessment of coronary artery disease by cardiac computed tomography. A statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 114, 1761-1791 (2006).
50. Budof MJ, Raggi P, Berman D et al.: Continuous probabilistic prediction of angiographically significant coronary artery disease using electron beam tomography. Circulation 105, 1791-1796 (2002).
51. Raggi P, Cooil B, Shaw L et al.: Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction. Am. J. Cardiol. 92, 827-829 (2003).
52. Shaw LJ, Raggi P, Schisterman E et al.: Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 28, 826-833 (2003).
53. Arad Y, Goodman KJ, Roth M et al.: Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J. Am. Coll. Cardiol. 46, 158-165 (2005).
54. de Vos AM, Prokop M, Roos CJ et al.: Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. Eur. Heart J. 29, 777-783 (2008).
55. Ding J, Kritchevsky SB, Hsu F et al.: Association between non-subcutaneous adiposity and calcified Coronary plaque: a substudy of the multi-ethnic study of atherosclerosis. Am. J. Clin. Nutr. 88, 645-650 (2008).
56. Sarin S, Wenger C, Marwaha A et al.: Clinical significance of epicardial fat measured using cardiac multislice computed tomography. Am. J. Cardiol. 102, 767-771 (2008).
57. Jeong JW, Jeong MH, Yun KH et al. Echocardiographic epicardial fat thickness and coronary artery disease: Circ. J. 71, 536-539 (2007).
58. Eroglu S, Sade LE, Yildirir A et al.: Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nut. Metab. Cardiovasc. Dis. DOI:10.1016/j.numecd.2008.05.002 (Epub ahead of print) (2008).
59. Djaberi R, Schuijf JD, van Werkhoven JM et al.: Relation of epicardial adipose tissue to coronary atherosclerosis. Am. J. Cardiol. 102(12), 1602-1607 (2008).
60. Chaowalit N, Somers VK, Pellikka P, Rihal CS, Lopez-Jimenez F: Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis 186, 354-359 (2006).
61. Gorter PM, de Vos AM, van der Graaf Y et al.: Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography. Am. J. Cardiol. 102, 380-385 (2008).
62. Jialal I, Stein D, Balis D et al.: Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitivity C-reactive protein levels. Circulation 103, 1933-1935 (2001).
63. Albert MA, Danielson E, Rifai N, Ridker PM: Effect of statin therapy on C-reactive protein levels: the Pravastatin Inflammation/CRP Evaluation (PRINCE): a randomized trial and cohort study. JAMA 286, 64-70 (2001).